Skip to main content
. Author manuscript; available in PMC: 2017 Jun 1.
Published in final edited form as: Semin Arthritis Rheum. 2016 Apr 8;45(6):648–655. doi: 10.1016/j.semarthrit.2016.04.001

Table 2.

Total SHOMRI at baseline and selected subscales and their delta values and progression rates over 1.5 years in subjects without (KL 0/1) versus with radiographic OA (KL 2/3)

Parameter Kellgren/Lawrence score
(KL)
P-
value*
KL 0/1 KL 2/3
Baseline SHOMRI
total
Values (median;
IQR)
7 (4–13.5) 12.5 (6–19.5) 0.024
Baseline SHOMRI
cartilage
Values (median;
IQR)
1 (0–2.5) 3 (1–8.5) 0.007
Baseline SHOMRI
BMEP**
Values (median;
IQR)
0 (0–0) 0 (0–0.5) 0.278
Baseline SHOMRI
subchondral cysts
Values (median;
IQR)
0 (0–0) 0 (0–1) 0.025
Baseline SHOMRI
labrum
Values (median;
IQR)
5.5 (3–9. 5) 6 (5–10) 0.085
Baseline SHOMRI
Lig. teres
Values (median;
IQR)
0 (0–1) 1 (0–2) 0.022
Evolution of
SHOMRI total
Delta values (median;
IQR)
0 (0–1) 0 (0–2) 0.615
Evolution of
SHOMRI cartilage
Delta values (median;
IQR)
0 (0–0) 0 (0–0) 0.509
Evolution of
SHOMRI BMEP**
Delta values (median;
IQR)
0 (0–0) 0 (0–0) 0.535
Evolution of
SHOMRI
subchondral cysts
Delta values (median;
IQR)
0 (0–0) 0 (0–0) 0.112
Evolution of
SHOMRI labrum
Delta values (median;
IQR)
0 (0–0) 0 (0–0) 0.593
Delta SHOMRI
ligamentum teres
Values (median;
IQR)
0 (0–0) 0 (0–0) 0.408
*

Fisher’s exact test was used for categorical data (presence/absence of abnormalities or progression yes/no), and the exact Mann-Whitney U test for nonparametric testing. Abnormality present applies to any SHOMRI sub-score >1. SHOMRI progression is any change >0 over time.

**

Bone-marrow edema pattern.